Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Illumina Laboratory Services, |
RCV001270882 | SCV001451661 | likely pathogenic | CSNK2A1-related neurodevelopmental syndrome | 2019-01-04 | criteria provided, single submitter | clinical testing | The CSNK2A1 c.997C>T (p.Arg333Ter) variant is a stop-gained variant that is predicted to result in a premature termination of the protein. A literature search was performed for the gene, cDNA change, and amino acid change. No publications were found based on this search. This variant is not found in the Genome Aggregation Database and is in a region of good sequencing coverage so the variant is presumed to be rare. The p.Arg333Ter variant is located barely outside of the protein kinase domain, where the majority of reported pathogenic missense variants are located. Based on the de novo state of the variant and its rarity, the CSNK2A1 p.Arg333Ter variant is classified as likely pathogenic for CSNK2A1-related neurodevelopmental syndrome. |